Super compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanisms

Experimental and Therapeutic Medicine

Volumn 9, Issue 4, 2015, Pages 1314-1318

  Wang, Qingjiang ^a   Zhang, Chunxiao ^a   Guo, Jinhui ^a   Huang, Jian ^a   Xi, Xiue ^a   Zhang, Ligong ^a   Cui, Xiuqin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Curative effect; Moxifloxacin; Multidrug resistant; Tuberculosis

Indexed keywords

AMIKACIN; B7 ANTIGEN; CD40 ANTIGEN; HLA DR ANTIGEN; MOXIFLOXACIN; PASINIAZID; PROPYLTHIOURACIL ISONICOTINOYL AMINE; PYRAZINAMIDE; RIFABUTIN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BEDTIME DOSAGE; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL DISEASE; HUMAN; LEUKOCYTE COUNT; LEUKOPENIA; LIVER INJURY; LUNG LESION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NEUROLOGICAL COMPLICATION; RADIODIAGNOSIS; SPUTUM SMEAR; TREATMENT OUTCOME;

EID: 84923058036     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2230     Document Type: Article

References (15)

1. Chen JL, Shi JW, Gu DL and Chen XL: The value of moxifloxacin and rifabutin strategy on super compact treatment of initial smear positive pulmonary tuberculosis. Chongqing Shi Yi 41: 2966-2968, 2012 (In Chinese).
2. Koh WJ, Lee SH, Kang YA, et al: Comparison of levofloxacin versus moxifloxacin for multidrug resistant tuberculosis. Am J Respir Crit Care Med 188: 858-864, 2013.
3. Chen WH, Xu B, Tang WQ, Zong XN, Luo PF, Cao S and Wei PM: Meta-analysis of refractory, recurrent and multi-drug resistant tuberculosis treatment by moxifloxacin. Nanjing Yi Ke Da Xue Xue Bao 30: 1166-1171, 2010 (In Chinese).
4. Jiang RH, Xu HB and Li L: Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study. Int J Antimicrob Agents 42: 36-41, 2013.
5. Chinese Medical Association: Guidance for Clinical Detection and Treatment (Tuberculosis). Beijing People's Medical Publishing House, pp87-91, 2005.
6. Manika K, Chatzika K, Zarogoulidis K and Kioumis I: Moxifloxacin in multidrug resistant tuberculosis: is there any indication for therapeutic drug monitoring? Eur Respir J 40: 1051-1053, 2012.
7. Nosova EY, Bukatina AA, Isaeva YD, Makarova MV, Galkina KY and Moroz AM: Analysis of mutations in the gyrA and gyrB genes and their association with the resistance of Mycobacterium tuberculosis to levofloxacin, moxifloxacin and gatifloxacin. J Med Microbiol 62: 108-113, 2013.
8. Zvada SP, Denti P, Geldenhuys H, et al: Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high dose rifapentine. Antimicrob Agents Chemother 56: 4471-4473, 2012.
9. Berdot S, Papy E, Rioux C, et al: Use of moxifloxacin in tuberculosis regimen in a French teaching hospital. Med Mal Infect 40: 568-573, 2010 (In French).
10. Abbate E, Vescovo M, Natiello M, et al: Successful alternative treatment of extensively drug resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine. J Antimicrob Chemother 67: 473-477, 2012.
11. Liu XY, Lin JX, Chen R and Peng DD: Clinical observation of super compact treatment of moxifloxacin in the initial treatment sputum positive pulmonary tuberculosis. Guangdong Yi Xue 32: 1749-1751, 2011 (In Chinese).
12. Fouad M and Gallagher JC: Moxifloxacin as an alternative or additive therapy for treatment of pulmonary tuberculosis. Ann Pharmacother 45: 1439-1444, 2011.
13. Pranger AD, van Altena R, Aarnoutse RE, et al: Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience. Eur Respir J 38: 888-894, 2011.
14. Balasubramanian V, Solapure S, Gaonkar S, et al: Effect of coadministration of moxifloxacin and rifampin on Mycobacterium tuberculosis in a murine aerosol infection model. Antimicrob Agents Chemother 56: 3054-3057, 2012.
15. Liang LL, Liu X and Ma Y: Effects of anti tuberculosis containing with moxifloxacin or levofloxacin on multidrug resistant pulmonary tuberculosis. Zhongguo Yi Yuan Xie Hui 14: 1451-1453, 2011 (In Chinese).